MARINA BIOTECH INC COM STK (DE)
MRNA
MRNA was delisted on the 1st of February, 2012.
2 hedge funds and large institutions have $2.7K invested in MARINA BIOTECH INC COM STK (DE) in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
16% less capital invested
Capital invested by funds: $3.2K → $2.7K (-$500)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
-$414 |
MRNA Hedge Fund Activity: Q2 2025 in Review
2 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in MARINA BIOTECH INC COM STK (DE) (MRNA) for Q2 2025, worth a combined $2.7K — down 16% from $3.2K a quarter earlier.
Fund positioning in MRNA was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Byrne Asset Management, cutting an estimated $414.
- 2 institutional investors held MARINA BIOTECH INC COM STK (DE) (MRNA) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $2.7K of MARINA BIOTECH INC COM STK (DE) stock for Q2 2025, down 16% quarter-over-quarter.
- 0 funds opened new MARINA BIOTECH INC COM STK (DE) positions in Q2 2025 and 0 closed out.
- The largest MARINA BIOTECH INC COM STK (DE) seller in Q2 2025 was Byrne Asset Management, an estimated $414 sold.
Based on aggregated 13F filings for Q2 2025.